cladribine has been researched along with Bone Marrow Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M; Kawa, K; Nakayama, M; Sawada, A; Yamada, K; Yasui, M | 1 |
| Bartkowiak, J; Bednarek, A; Chojnowski, K; Chudobinski, C; Kordek, R; Robak, P; Robak, T; Urbanska-Rys, H | 1 |
| Betticher, DC; Cerny, T; Fey, MF; Hess, U; Meier, V; Rabaglio, M; Stalder, M; Zulian, G | 1 |
| Betticher, DC; Fey, MF; Gratwohl, A; Hess, U; Jenzer, H; Lohri, A; Pagani, O; Pugin, P; Tobler, A; von Rohr, A | 1 |
| Florena, AM; Franco, V; Musso, M; Quintini, G | 1 |
| Foon, KA; Piro, LD; Saven, A | 1 |
| Hurria, A; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS | 1 |
| Beham-Schmid, C; Höfler, G; Linkesch, W; Schmidt, HH; Sill, H | 1 |
| Bennett, B; Canfield, VA; Guiney, P; Nichols, C; Vose, J | 1 |
| Albitar, M; Anderlini, P; Andersson, B; Beran, M; Champlin, R; Claxton, D; Estey, E; Gajewski, J; Giralt, S; Kantarjian, H; Keating, M; Khouri, I; Koller, C; Kornblau, S; Kørbling, M; Mehra, R; O'Brien, S; Przepiorka, D; Rondón, G; van Besien, K | 1 |
| Amir, G; Bennett, M; Gillis, S; Polliack, A | 1 |
| Błoński, JZ; Góra-Tybor, J; Kasznicki, M; Lech-Marańda, E; Robak, T | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Kay, AC; Piro, LD; Saven, A; Thurston, D | 1 |
6 trial(s) available for cladribine and Bone Marrow Diseases
| Article | Year |
|---|---|
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Diseases; Chronic Disease; Cladribine; Female; Humans; Immunocompromised Host; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Opportunistic Infections; Prospective Studies; Treatment Outcome | 1994 |
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Opportunistic Infections; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 1996 |
2-Chlorodeoxyadenosine as initial therapy for advanced low grade lymphomas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Cladribine; Disease-Free Survival; Female; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Treatment Outcome | 1997 |
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cladribine; Combined Modality Therapy; Cytarabine; Feasibility Studies; Female; Filgrastim; Graft vs Host Reaction; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Recombinant Proteins; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine | 1997 |
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cladribine; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Remission Induction; Salvage Therapy; Treatment Outcome | 2001 |
2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bacterial Infections; Bone Marrow Diseases; Cladribine; Deoxyadenosines; Drug Evaluation; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Treatment Outcome | 1992 |
7 other study(ies) available for cladribine and Bone Marrow Diseases
| Article | Year |
|---|---|
Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain.
Topics: Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bone Marrow Transplantation; Brain Diseases; Child; Cladribine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Prognosis; Recurrence; Transfusion Reaction; Xanthogranuloma, Juvenile | 2012 |
High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cladribine; Cyclophosphamide; Female; Humans; Lung Diseases; Lymphomatoid Granulomatosis; Middle Aged; Rituximab | 2006 |
Cladribine and severe myelotoxicity.
Topics: Aged; Bone Marrow Diseases; Cladribine; Humans; Male; Middle Aged | 1993 |
Bone marrow granulomas in hairy cell leukaemia following 2-chlorodeoxyadenosine therapy.
Topics: Adult; Bone Marrow; Bone Marrow Diseases; Cladribine; Granuloma; Humans; Leukemia, Hairy Cell; Male | 1994 |
2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis.
Topics: Adult; Bone Marrow Diseases; Cladribine; Female; Histiocytosis, Langerhans-Cell; Humans; Male; Middle Aged; Remission Induction | 1994 |
Bone marrow granulomas in hairy cell leukaemia.
Topics: Bone Marrow Diseases; Cladribine; Granuloma; Humans; Leukemia, Hairy Cell; Male; Middle Aged | 1996 |
Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Blood Cell Count; Bone Marrow Diseases; Bone Marrow Examination; Cladribine; Combined Modality Therapy; Follow-Up Studies; Hematopoiesis; Humans; Interferons; Leukemia, Hairy Cell; Male; Middle Aged; Pentostatin; Remission Induction; Splenectomy | 2001 |